Below are the most recent publications written about "Macular Edema" by people in Profiles.
-
Paruchuri SS, Mahmoudzadeh R, Wheeler S, Randolph J. Prevention and management of postcataract cystoid macular edema. Curr Opin Ophthalmol. 2025 May 01; 36(3):182-188.
-
Magrath G, Luvisi J, Russakoff D, Oakley J, Say EA, Blice J, Jayagopal A, Tucker S, Loayza A, Baker GH, Obeid JS. Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study. Am J Ophthalmol. 2025 May; 273:176-181.
-
Kalavar M, Sridhar J. Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. Curr Opin Ophthalmol. 2025 May 01; 36(3):189-198.
-
Gonzales J, Acharya NR, Sugar EA, Burke AE, Vitale AT, Gupta V, Dunn JP, Lightman SL, Thorne JE, Kim RY, Yeh S, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA. Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment. Ophthalmology. 2025 May; 132(5):527-537.
-
Bowe T, Richards CJ, Mansour HA, Ali FS, Sridhar J, Williams JBK, Yonekawa Y, Cohen MN, Xu D, Deaner JD, Sivalingam M, Orlin A, Patel S, Kuriyan AE. Disparities Between Clinical Trial Recruitment and Real-World Demographics in Macular Edema Secondary to Retinal Vein Occlusion. Am J Ophthalmol. 2025 Jan; 269:429-434.
-
Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol. 2024 Aug 22; 108(9):1257-1262.
-
Sharma A, Wakabayashi T, Regillo CD, Cheung CMG, Loewenstein A, Zur D, Goldberg D, Hilely A, Ozdek S, ?zdemir HB, Parachuri N, Kumar N, Kuppermann BD, Bandello F, Querques G. Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study. Eye (Lond). 2024 Dec; 38(17):3272-3278.
-
Momenaei B, Pandit SA, Wang KY, Wakabayashi T, Hsu J, Regillo CD, Klufas MA, Xu D, Cohen MN, Garg SJ, Kuriyan AE, Yonekawa Y. SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE FOR REFRACTORY POSTOPERATIVE CYSTOID MACULAR EDEMA. Retina. 2024 08 01; 44(8):1379-1386.
-
Sharma S, Belenje A, Takkar B, Narula R, Rathi VM, Tyagi M, Rani PK, Narayanan R, Kaur I. Tear Protein Markers for Diabetic Retinopathy and Diabetic Macular Edema - Towards an Early Diagnosis and Better Prognosis. Semin Ophthalmol. 2024 Aug; 39(6):440-450.
-
Cai CX, Nishimura A, Bowring MG, Westlund E, Tran D, Ng JH, Nagy P, Cook M, McLeggon JA, DuVall SL, Matheny ME, Golozar A, Ostropolets A, Minty E, Desai P, Bu F, Toy B, Hribar M, Falconer T, Zhang L, Lawrence-Archer L, Boland MV, Goetz K, Hall N, Shoaibi A, Reps J, Sena AG, Blacketer C, Swerdel J, Jhaveri KD, Lee E, Gilbert Z, Zeger SL, Crews DC, Suchard MA, Hripcsak G, Ryan PB. Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study. Ophthalmol Retina. 2024 Aug; 8(8):733-743.